Home » Stocks » QDEL

Quidel Corporation (QDEL)

Stock Price: $116.39 USD -4.54 (-3.75%)
Updated May 10, 2021 4:00 PM EDT - Market closed
After-hours: $116.40 +0.01 (0.01%) May 10, 5:58 PM
Market Cap 4.96B
Revenue (ttm) 1.86B
Net Income (ttm) 948.13M
Shares Out 42.51M
EPS (ttm) 21.74
PE Ratio 5.35
Forward PE 20.33
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $116.39
Previous Close $120.93
Change ($) -4.54
Change (%) -3.75%
Day's Open 120.10
Day's Range 115.20 - 121.10
Day's Volume 926,530
52-Week Range 104.40 - 306.72

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Investors rewarded the stock for triple-digit growth, but the market remains unsure about the remainder of 2021.

3 days ago - The Motley Fool

Quidel (QDEL) delivered earnings and revenue surprises of -10.06% and 0.03%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 days ago - Zacks Investment Research

Shares of Quidel (NASDAQ:QDEL) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 259.02% year over year to $4.38, which missed the e...

4 days ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financia...

4 days ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

4 days ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today ...

6 days ago - Business Wire

Quidel (QDEL) is likely to have witnessed recovery in rapid immunoassay revenues during Q1.

6 days ago - Zacks Investment Research

An important indicator for investors to consider could be a stock's 52-week trading range, the range showing the lowest and highest price a particular stock traded over the trailing year. Finding stocks...

Other stocks mentioned: IRTC, METX, SPLK
1 week ago - Benzinga

Bear of the Day: Quidel (QDEL)

1 week ago - Zacks Investment Research

Diagnostic test manufacturer Quidel's stock has slumped for good reason. Even so, this might be a good time to buy it.

1 week ago - The Motley Fool

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

AJRD, HRTG, LMB, QDEL, and SPFI have been added to the Zacks Rank #5 (Strong Sell) List on April 29, 2021

Other stocks mentioned: AJRD, HRTG, LMB, SPFI
1 week ago - Zacks Investment Research

Market sentiment about these formerly hot stocks has soured, but there are positive catalysts for both on the horizon.

Other stocks mentioned: TDOC
1 week ago - The Motley Fool

FBC, IDCC, PAAS, COG, and QDEL have been added to the Zacks Rank #5 (Strong Sell) List on April 27, 2021

Other stocks mentioned: COG, FBC, IDCC, PAAS
1 week ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--May 5 webinar to help physicians differentiate between Lyme disease and COVID-19 is the latest in an ongoing series sponsored by Quidel.

1 week ago - Business Wire

Although these stocks are down of late, their promising growth opportunities could lift them back up.

Other stocks mentioned: FUBO
1 week ago - The Motley Fool

The stock price of Quidel Corporation, a clinical genetic testing company, has seen a 10% drop in just five trading sessions. The decline was driven primarily due to the company's preliminary report for...

1 week ago - Forbes

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fisc...

1 week ago - Business Wire

Quidel Corporation (NASDAQ: QDEL) shares witnessed a drop after announcing lower-than-expected preliminary results for Q1 of 2021 after the bell on Thursday. The company expects Q1 revenues in the range...

2 weeks ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

2 weeks ago - Business Wire

Less COVID-19 testing means less revenue for some companies.

Other stocks mentioned: ABT, BDX, FLGT
2 weeks ago - The Motley Fool

Quidel (QDEL) closed the most recent trading day at $119.01, moving -0.42% from the previous trading session.

2 weeks ago - Zacks Investment Research

Quidel (QDEL) closed at $129.24 in the latest trading session, marking a -0.28% move from the prior day.

3 weeks ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)-- #bayarealymefoundation--Quidel Corporation partners with the Bay Area Lyme Foundation to help heighten public awareness to Lyme disease.

3 weeks ago - Business Wire

Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of pro...

Other stocks mentioned: GNMK, LMNX, RHHBY
4 weeks ago - GuruFocus

Quidel (QDEL) closed the most recent trading day at $128.33, moving -1.47% from the previous trading session.

1 month ago - Zacks Investment Research

WALTHAM, Mass.--(BUSINESS WIRE)--Quidel Taps ICS to Collaborate on Next-Gen Multiplex Molecular Diagnostic Instruments for SARS-CoV-2/COVID Pathogen Detection

1 month ago - Business Wire

Quidel's over-the-counter Covid test receives emergency use authorization from FDA

YouTube video

Quidel CEO Douglas Bryant joins 'Closing Bell' to discuss his company's new Covid-19 test, which is available to individuals without a prescription, provided they agree to test twice within 24-36 hours.

1 month ago - CNBC Television

SAN DIEGO--(BUSINESS WIRE)-- #Lyme--Quidel, the nation's leading developer of rapid Lyme disease testing, cautions Americans to be vigilant, take precautions and get tested if in doubt.

1 month ago - Business Wire

As of April 1, the three stocks below appear to be undervalued by the market as their price-earnings ratios without non-recurring items stand below 20 while their price-earnings to growth ratios are nea...

Other stocks mentioned: ESNT, TX
1 month ago - GuruFocus

Coronavirus testing: Quidel receives EUA from FDA for swab-based COVID-19 tests

YouTube video

Yahoo Finance's Kristin Myers and Anjalee Khemlani spoke to Quidel CEO Douglas Bryant about receiving emergency use authorization from the FDA for the company's swab-based COVID-19 tests.

1 month ago - Yahoo Finance

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

1 month ago - Business Wire

Quidel (QDEL) closed at $130.31 in the latest trading session, marking a +1.86% move from the prior day.

1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

1 month ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

1 month ago - Business Wire

For a little less volatility and a little more dependability in 2021, check out these companies.

Other stocks mentioned: ABT, CVS
1 month ago - The Motley Fool

In the latest trading session, Quidel (QDEL) closed at $126.30, marking a +0.13% move from the previous day.

1 month ago - Zacks Investment Research

With everyone tired of Covid-19 lockdowns and protocols, it's hard to see QDEL stock as a confident contrarian trade. The post Covid Fatigue Threatens to Derail Once Relevant Quidel appeared first on In...

1 month ago - InvestorPlace

Investors are down on Quidel, but there is plenty of reason for optimism.

1 month ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announc...

1 month ago - Business Wire

Quidel (QDEL) closed the most recent trading day at $138.90, moving -1.53% from the previous trading session.

1 month ago - Zacks Investment Research

The stock price of Quidel Corporation, a manufacturer of diagnostic healthcare products, has seen a large 19% drop over the last ten trading days, while it is down 9% over the last five trading days. We...

1 month ago - Forbes

The pandemic won't always be a pandemic, but the virus is going to with us as an endemic part of life. That's the message from a new piece on Reuters.

Other stocks mentioned: ABT, APT, BNOW
2 months ago - OTC PR Wire

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, annou...

2 months ago - Business Wire

SILVER SPRING, Md., March 1, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen ...

2 months ago - PRNewsWire

Investors in search of opportunities amid growing companies could be interested in the following three stocks, as their share prices are trading lower than their Peter Lynch Fair Values.

Other stocks mentioned: HIG, TOL
2 months ago - GuruFocus

Investors are starting to get worried now that COVID-19 is possibly declining.

2 months ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today ...

2 months ago - Business Wire

It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.

Other stocks mentioned: ABT, BDX, FLGT
2 months ago - The Motley Fool

The company released its fourth-quarter and full-year 2020 earnings report.

2 months ago - The Motley Fool

About QDEL

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables... [Read more...]

Industry
Diagnostics & Research
Founded
1979
CEO
Douglas Bryant
Employees
1,370
Stock Exchange
NASDAQ
Ticker Symbol
QDEL
Full Company Profile

Financial Performance

In 2020, QDEL's revenue was $1.66 billion, an increase of 210.66% compared to the previous year's $534.89 million. Earnings were $810.29 million, an increase of 1,011.18%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 172.75, which is an increase of 48.42% from the latest price.

Price Target
$172.75
(48.42% upside)
Analyst Consensus: Buy